June 16th, 20210On Wednesday, a U.S. hospital will give the first infusion of an expensive, controversial new Alzheimer’s drug from Biogen Inc. before Medicare had even said what it will pay for — and with some doctors upset by its approval last week.
The first administration of the drug, Aduhelm, outside of a clinical trial is scheduled to take...
May 12th, 20200The following article is contributed by Donna Jawad, Community Outreach Specialist at the Michigan Center for Contextual Factors in Alzheimer’s Disease (MCCFAD). It has been edited for style
As we learn more about Alzheimer’s Disease and related dementias, one should keep in mind that though we have not yet found a cure, there are...
February 27th, 20200DEARBORN HEIGHTS — At a community gathering on Saturday, Feb. 15, organized by the Michigan Center for Contextual Factors in Alzheimer’s Disease (MCCFAD) at the University of Michigan, elderly Arab Americans and their families learned of new approaches to long-term care and prevention and joined in a lively discussion.
Held at...
